Pulmonx Corporation Share Price
Equities
LUNG
US7458481014
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.815 USD | +3.87% |
|
-14.88% | -59.13% |
| Capitalization | 109M 94.66M 88.85M 80.82M 148M 9.42B 168M 1.04B 405M 4.3B 409M 401M 15.83B | P/E ratio 2025 * |
-1.75x | P/E ratio 2026 * | -1.96x |
|---|---|---|---|---|---|
| Enterprise value | 109M 94.66M 88.85M 80.82M 148M 9.42B 168M 1.04B 405M 4.3B 409M 401M 15.83B | EV / Sales 2025 * |
1.12x | EV / Sales 2026 * | 0.95x |
| Free-Float |
94.99% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Pulmonx Corporation
More recommendations
More press releases
More news
| 1 day | +3.87% | ||
| 1 week | -14.88% | ||
| Current month | -18.38% | ||
| 1 month | -16.92% | ||
| 3 months | -65.18% | ||
| 6 months | -54.51% | ||
| Current year | -59.13% |
| 1 week | 2.62 |  | 3.27 |
| 1 month | 2.62 | | 3.56 |
| Current year | 2.62 | | 9.37 |
| 1 year | 2.62 | | 9.37 |
| 3 years | 2.62 | | 24.48 |
| 5 years | 2.62 | | 69.48 |
| 10 years | 2.62 | | 69.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 14/03/2024 | |
Mehul Joshi
DFI | Director of Finance/CFO | 64 | 02/04/2024 |
| Chief Tech/Sci/R&D Officer | - | 29/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Ferrari
BRD | Director/Board Member | 71 | 31/01/2007 |
Dana Mead
CHM | Chairman | 65 | 30/09/2019 |
Glendon French
BRD | Director/Board Member | 63 | 17/12/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.87% | -14.88% | -52.93% | -80.98% | 109M | ||
| -0.01% | +0.01% | +0.01% | +111.65% | 12.57B | ||
| +0.28% | +1.50% | +46.06% | +110.55% | 9.91B | ||
| +1.42% | -3.49% | +18.69% | +27.03% | 8.64B | ||
| -1.07% | +1.50% | +30.91% | +169.63% | 5.5B | ||
| +0.11% | -3.64% | +3.75% | -16.47% | 5.27B | ||
| -0.31% | -3.86% | -10.83% | +37.08% | 4.93B | ||
| +0.05% | -.--% | +84.99% | +31.29% | 4.7B | ||
| +0.04% | -3.21% | +3.43% | +29.14% | 4.23B | ||
| -0.95% | -0.81% | -11.42% | -70.69% | 1.94B | ||
| Average | +0.33% | -2.10% | +11.27% | +34.82% | 5.78B | |
| Weighted average by Cap. | +0.11% | -1.27% | +19.73% | +67.23% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 97.02M 84.19M 79.02M 71.87M 132M 8.38B 149M 923M 360M 3.83B 364M 356M 14.08B | 115M 99.37M 93.27M 84.84M 156M 9.89B 176M 1.09B 425M 4.52B 430M 421M 16.62B |
| Net income | -62.01M -53.81M -50.5M -45.94M -84.31M -5.35B -95.35M -590M -230M -2.45B -233M -228M -9B | -56.6M -49.11M -46.09M -41.93M -76.95M -4.89B -87.03M -538M -210M -2.23B -212M -208M -8.21B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
291
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/25 | 2.775 $ | +2.40% | 95,279 |
| 17/06/25 | 2.710 $ | -9.06% | 310,201 |
| 16/06/25 | 2.980 $ | -1.65% | 161,296 |
| 13/06/25 | 3.030 $ | -3.50% | 179,459 |
| 12/06/25 | 3.140 $ | -3.68% | 136,454 |
Delayed Quote Nasdaq, June 18, 2025 at 04:30 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2.710USD
Average target price
11.31USD
Spread / Average Target
+317.24%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LUNG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition